Global Law Firm Rimon PC Adds Three Intellectual Property Partners to Washington, D.C. Office
News November 9, 2021
Washington, D.C. – Increasing its team of pharmaceutical and biotech IP attorneys, Rimon is pleased to welcome Dr. Ping Wang, Dr. Michael Ye, and Dr. John Murray as Intellectual Property and Patent Prosecution partners in the firm’s Washington D.C. office.
The group joins the firm from Morris Manning and Martin, LLP.
“Pharma and biotech are foundational parts of the world economy, and we are very happy to be able to add Ping, Michael, and John, all of whom have exceptional experience in these industries, to our IP team in D.C.,” said Michael Moradzadeh, CEO and Founding Partner of Rimon. “Their exceptional IP work in the United States and China and experience in prominent industries such as pharmaceuticals make them great additions to our global team.”
Dr. Wang focuses her practice on all aspects of intellectual property, including patent prosecution, inter partes review, post grand review, interference practice, counseling and opinions regarding patentability, patent invalidity, freedom-to-operate, infringement, design around, and diligence work in connection with mergers and acquisitions in the biotechnology industry. She also handles IPR, patent infringement, and other litigation matters, as well as licensing negotiations, information technology and academic agreements, and acquisitions of capital for entrepreneurs, start-ups, and institutions.
Dr. Wang has been recognized by Chambers & Partners, by IAM Patent 1000, and as IP Star. She has well-established relationships throughout the world, which enable swifter patent prosecution outside of the United States. She negotiates and handles business transactions on behalf of her clients, with a particular focus on business negotiations and transactions between the United States and China.
“There were a few key factors that brought us to Rimon. First, I respect the leadership here, which gives attorneys ownership over their practice, flexibility, and always puts the clients’ best interests at the forefront. Second is the new platform and network of global partners, which is best to serve clients across different jurisdictions at a low cost due to low overhead and no internal bureaucracy. I believe this should be the future of legal, and Rimon is the pioneer,” said Dr. Wang.
Dr. Ye represents clients in patent prosecution, opinion work, due diligence and licensing, as well as trademark prosecution and licensing, and copyright. He also handles inbound and outbound negotiations and transactions in China. He has handled drafting and prosecuting patent applications globally, inter partes review and post grant proceedings, product clearance searches, product evaluations, inventorship analysis, non-disclosure agreements and licensing agreements. He has been named in IAM Patent 1000 and has substantial experience across the breadth of life sciences, including in biotechnology, chemistry/organic chemistry, bioinformatics, cosmetics, pharmaceuticals, medical devices, agriculture, and artificial intelligence.
Dr. Murray represents clients in complex life sciences patent litigation, prosecution and opinion work, as well as due diligence. He conducts prosecution both domestically and internationally for a wide range of clients, including start-ups and academic clients, as well as larger corporations. Dr. Murray has substantial experience in biotechnology, chemistry/organic chemistry, medical devices, molecular biology, and pharmaceuticals, as well as software. His work includes patent infringement litigation, Hatch-Waxman, and ITC 337 litigation.
Dr. Wang graduated from the University of New Hampshire (J.D.) and Kumming Medical University (M.D.).
Dr. Ye graduated from Georgetown University (J.D.), University of Pennsylvania (Ph.D. Biochemistry and Molecular Biology), and Peking University (B.S., Biochemistry).
Dr. Murray graduated from Fordham University (J.D.), Columbia University (Post-Doctoral Fellow), Mt. Sinai School of Medicine (Post-Doctoral Fellow), University of Leicester (Ph.D., Molecular Genetics), and from the University of Edinburgh (B.S Biological Sciences, Genetics).
Rimon has 45 offices across five continents. The firm is widely known as being at the vanguard of legal innovation. The firm has been repeatedly recognized by the Financial Times as one of North America’s most innovative law firms. The firm’s Managing Partners were both named ‘Legal Rebels’ by the American Bar Association’s ABA Journal and have spoken on innovations in the practice of law at Harvard and Stanford Law Schools. Rimon and its lawyers have also received numerous awards for excellence, including from Best Lawyers and Chambers.